SBIR/STTR Research Award
Unique Topical Treatment for UV-Induced Skin Cancer
Award amount
$119,962Program and phase
SBIR · Phase IAward year
2003Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- BIOMEDICAL DEVELOPMENT CORP
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- CATLLUJNR7W4
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
DESCRIPTION (provided by applicant): The goal of this project is to develop a polymer-based vehicle for the topical delivery of caffeine to inhibit UV-induced skin cancer. Despite increased use of sun screen, skin cancer rates continue to rise. Recently, caffeine has been shown to inhibit carcinogenesis in murine models of UV-induced skin tumor formation. The polymer-based delivery system described in this proposal seeks to improve the efficacy and convenience of topically applied caffeine for this application.
To achieve this goal, the following Specific Aims will be pursued:
Aim 1. Formulate a Polymer-based Topical Delivery System Containing Caffeine
Aim 2. Evaluate the Effect of Caffeine Delivered from the Polymer-based Vehicle on
Ultraviolet Light-induced Skin Cancer Using a Mouse Model.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Real World Adoption of an OUD Digital Health Therapeutic
- Real World Adoption of an OUD Digital Health Therapeutic
- mHealth for Patient Self-Management of Opioid Use Disorder
- mHealth for Patient Self-Management of Opioid Use Disorder
- Nonlinear Computation Tool to Chart Trajectories of Bipolar Disorder
Research funding history
64 SBIR/STTR records share this UEI (1985–2025). Reported award amounts total $18,429,764. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, Department of Agriculture